Literature DB >> 33937972

Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

Mbathio Dieng1,2, Sarah J Lord3, Omgo E Nieweg4,5, Robyn P M Saw4, Andrew J Einstein6,7, Amanda A G Nijhuis4, Robin M Turner8, John F Thompson4, Rachael L Morton3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33937972     DOI： 10.1245/s10434-021-09821-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

Review 1.  Effective doses in radiology and diagnostic nuclear medicine: a catalog.

Authors:  Fred A Mettler; Walter Huda; Terry T Yoshizumi; Mahadevappa Mahesh
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

2.  CT and PET-CT Surveillance in Stages 3A to 3D Melanoma Results in More False-Positive than True-Positive Findings and Should Not be Routinely Recommended.

Authors:  Nicholas A Taylor; David G Brodland
Journal:  Ann Surg Oncol       Date:  2021-03-18       Impact factor: 5.344

3.  Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

Authors:  Mbathio Dieng; Sarah J Lord; Omgo E Nieweg; Robyn P M Saw; Andrew J Einstein; Amanda A G Nijhuis; Robin M Turner; John F Thompson; Rachael L Morton
Journal:  Ann Surg Oncol       Date:  2021-05-02       Impact factor: 5.344
  3 in total
  3 in total

1.  ASO Author Reflections: Longitudinal Diagnostic Accuracy of Surveillance Imaging in Resected Stage III Melanoma Patients.

Authors:  Mbathio Dieng; Rachael L Morton
Journal:  Ann Surg Oncol       Date:  2021-01-02       Impact factor: 5.344

2.  CT and PET-CT Surveillance in Stages 3A to 3D Melanoma Results in More False-Positive than True-Positive Findings and Should Not be Routinely Recommended.

Authors:  Nicholas A Taylor; David G Brodland
Journal:  Ann Surg Oncol       Date:  2021-03-18       Impact factor: 5.344

3.  Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

Authors:  Mbathio Dieng; Sarah J Lord; Omgo E Nieweg; Robyn P M Saw; Andrew J Einstein; Amanda A G Nijhuis; Robin M Turner; John F Thompson; Rachael L Morton
Journal:  Ann Surg Oncol       Date:  2021-05-02       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.